Serum free light chain analysis

被引：33

作者：

Davids, Matthew S. ^{[1
,2
]}

Murali, Mandakolathur R. ^{[2
,3
]}

Kuter, David J. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Hematol, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 10期

关键词：

INDEPENDENT RISK-FACTOR; MONOCLONAL GAMMOPATHY; PROGRESSION; URINE; RATIO; IMMUNOFIXATION; AMYLOIDOSIS; REDUCTION; SURVIVAL; MARKERS;

D O I：

10.1002/ajh.21815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In a variety of hematologic malignancies, immunoglobulin light chains (LC) are overproduced clonally and circulate without being linked by disulphide bonds to the immunoglobulin heavy chain. The recent development of a robust assay known as kappa and gamma "free'' LC (FLC) to quantify the levels of these unbound LC in the serum, and thereby determine their ratio, has led to an explosion of studies that demonstrate its utility in a wide range of hematologic disorders. This article summarizes laboratory testing for serum FLC, with a particular focus on clinical applications for the test. Am. J. Hematol. 85:787-790, 2010. (C) 2010 Wiley-Liss, Inc.

引用

页码：787 / 790

页数：4

共 50 条

[21] Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions
Graziani, Maria Stella
Merlini, Giampaolo
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (01) : 55 - 66
[22] Serum Free Light Chain Predict Overall Survival and Response to Therapy in Patients with Newly Diagnosed Multiple Myeloma
Meddour, Yanis
Rahali, Momahed C.
Belakehal, Salah E.
Ardjoun, Fatma Z.
Chaib, Samia
Djidjik, Reda
CLINICAL LABORATORY, 2018, 64 (04) : 551 - 558
[23] Serum Free Light Chain Response After 2 Courses of Induction Chemotherapy Predicts Prognosis in Myeloma Patients
Yagci, Munci
Karakaya, Fatih
Suyani, Elif
Haznedar, Rauf
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (02) : 98 - 102
[24] Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers
Yun, Shin Young
Rim, John Hoon
Park, Hak
Kang, Hyein
Lee, Sang-Guk
Lim, Jong-Baeck
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (07) : 1288 - 1299
[25] Comparison of Serum Immunofixation Electrophoresis and Free Light Chain Assays in the Detection of Monoclonal Gammopathies
Wood, Prescilla B.
McElroy, Yolonda G.
Stone, Marvin J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (04) : 278 - 280
[26] Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Maurer, Matthew J.
Cerhan, James R.
Katzmann, Jerry A.
Link, Brian K.
Allmer, Cristine
Zent, Clive S.
Call, Timothy G.
Rabe, Kari G.
Hanson, Curtis A.
Kay, Neil E.
Slager, Susan L.
Witzig, Thomas E.
Shanafelt, Tait D.
BLOOD, 2011, 118 (10) : 2821 - 2826
[27] Usefulness of free light chain measurement in monoclonal gammopathy, other haematological malignancies and autoimmune diseases
Verebi, Camille
Talbot, Alexis
Gendron, Nicolas
Hurtado-Nedelec, Margarita
HEMATOLOGIE, 2020, 26 (01): : 36 - 48
[28] Prediction of Response and Progression in Multiple Myeloma With Serum Free Light Chains Assay: Corroboration of the Serum Free Light Chain Response Definitions
Khoriaty, Rami
Hussein, Mohamad A.
Faiman, Beth
Kelly, Megan
Kalaycio, Matt
Baz, Rachid
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (01) : E10 - E13
[29] Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis
Weiss, Brendan M.
Hebreo, Joseph
Cordaro, Daniel V.
Roschewski, Mark J.
Baker, Thomas P.
Abbott, Kevin C.
Olson, Stephen W.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2699 - +
[30] Polyclonal Free Light Chain of Ig May Interfere with Interpretation of Monoclonal Free Light Chain κ/λ Ratio
Levinson, Stanley S.
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2010, 40 (04) : 348 - 353

← 1 2 3 4 5 →